India’s drug regulator stated on Thursday that it had inspected Marion Biotech’s manufacturing facility and promised extra motion based mostly on the probe report after the corporate’s cough syrup was linked to the loss of life of 18 kids in Uzbekistan. The drug regulator reviewed the corporate’s Noida facility within the Uttar Pradesh state and is in common contact with its Uzbekistan counterpart, the Indian well being ministry stated in a press release.